SWA
Sutton Wealth Advisors’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $227K | Sell |
6,275
-46
| -0.7% | -$1.67K | 0.11% | 98 |
|
2023
Q2 | $225K | Buy |
6,321
+425
| +7% | +$15.1K | 0.11% | 98 |
|
2023
Q1 | $210K | Hold |
5,896
| – | – | 0.11% | 98 |
|
2022
Q4 | $207K | Sell |
5,896
-2,167
| -27% | -$76.1K | 0.08% | 169 |
|
2022
Q3 | $237K | Buy |
8,063
+5,181
| +180% | +$152K | 0.1% | 150 |
|
2022
Q2 | $125K | Buy |
2,882
+1,371
| +91% | +$59.7K | 0.05% | 212 |
|
2022
Q1 | $65.8K | Buy |
1,511
+1,372
| +987% | +$59.8K | 0.02% | 332 |
|
2021
Q4 | $6.13K | Hold |
139
| – | – | ﹤0.01% | 1041 |
|
2021
Q3 | $5.31K | Hold |
139
| – | – | ﹤0.01% | 1045 |
|
2021
Q2 | $5.54K | Hold |
139
| – | – | ﹤0.01% | 1030 |
|
2021
Q1 | $4.96K | Sell |
139
-9
| -6% | -$321 | ﹤0.01% | 1016 |
|
2020
Q4 | $5.45K | Buy |
148
+9
| +6% | +$331 | ﹤0.01% | 962 |
|
2020
Q3 | $5.23K | Hold |
139
| – | – | ﹤0.01% | 919 |
|
2020
Q2 | $5.67K | Hold |
139
| – | – | ﹤0.01% | 838 |
|
2020
Q1 | $5.27K | Hold |
139
| – | – | ﹤0.01% | 806 |
|
2019
Q4 | $6.53K | Hold |
139
| – | – | ﹤0.01% | 905 |
|
2019
Q3 | $5.93K | Hold |
139
| – | – | ﹤0.01% | 913 |
|
2019
Q2 | $5.56K | Sell |
139
-120
| -46% | -$4.8K | ﹤0.01% | 909 |
|
2019
Q1 | $10.8K | Hold |
259
| – | – | 0.01% | 768 |
|
2018
Q4 | $9.9K | Sell |
259
-328
| -56% | -$12.5K | 0.01% | 746 |
|
2018
Q3 | $23.6K | Hold |
587
| – | – | 0.02% | 525 |
|
2018
Q2 | $23.7K | Hold |
587
| – | – | 0.02% | 537 |
|
2018
Q1 | $22.9K | Hold |
587
| – | – | 0.02% | 518 |
|
2017
Q4 | $20.8K | Sell |
587
-333
| -36% | -$11.8K | 0.02% | 546 |
|
2017
Q3 | $37.4K | Hold |
920
| – | – | 0.03% | 344 |
|
2017
Q2 | $39.7K | Hold |
920
| – | – | 0.03% | 310 |
|
2017
Q1 | $38.8K | Hold |
920
| – | – | 0.03% | 309 |
|
2016
Q4 | $35.4K | Buy |
920
+81
| +10% | +$3.12K | 0.03% | 327 |
|
2016
Q3 | $36.2K | Hold |
839
| – | – | 0.03% | 310 |
|
2016
Q2 | $36.4K | Hold |
839
| – | – | 0.03% | 295 |
|
2016
Q1 | $34K | Buy |
+839
| New | +$34K | 0.03% | 312 |
|